PRUNUS Therapeutics
Sustainable therapeutics via synthetic biology
Sustainable therapeutics via synthetic biology
PRUNUS Therapeutics is a biotechnology startup that focuses on sustainable therapeutics via synthetic biology. Founded in 2016, the company's main platform is dedicated to the discovery and development of innovative therapeutics and diagnostics for human and animal healthcare, with a specific emphasis on sustainable cancer treatment. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries.
As of now, details about the company's headquarters and its last investment are not available. PRUNUS Therapeutics presents an intriguing investment opportunity for venture capital firms interested in supporting groundbreaking advancements in the field of synthetic biology and sustainable healthcare.
There is no investment information
No recent news or press coverage available for PRUNUS Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
